Chronic inflammation, as indicated by the continuous presence of serum inflammatory mediators such as C-reactive protein (CRP), fibrinogen, and various interleukins, is a risk factor for numerous age-related, chronic disorders such as diabetes, cardiovascular disease (CVD), cancer, and the metabolic syndrome (1, 2), as well as increased frailty and cognitive decline (3). This evidence concerns the gene CRP and metabolic syndrome.